LLJ at EuroNanoForum 2017

LLJ is exhibiting alongside a few other nanotechnology projects on a stand organised by the Nano Industries Association at this year’s EuroNanoForum held in Valetta, Malta 21-23 June. Around 1000 delegates have gathered to gain a snap shot of not only what projects are being supported by the Framework Programme but also measures being taken to support innovation.

LifeLongJoints at EuroNanoForum 2017 (Booth 17)

On the exhibition stand itself, the NIA organised two very interesting presentations relating to regulation development for nano-technologies embedded in products which generate some thoughtful discussion. Guillaume Flament, working for NIA based in Paris gave an overview of the current regulatory framework, followed by Anthony Bochon a lawyer specialising in nano-technology compliance with Squire Patton Boggs, who discussed the legal position that companies need to take account of. This generated quite a bit of discussion over how to ensure good management of risks while not discouraging innovation.

LLJ is an example of a development that can shine positive benefits of nano-technologies, but as with all new medical device developments has now to take into account a more stringent compliance regime following the introduction of the new Medical Devices Regulation which takes effect from 2020.

Launch of CEN Workshop based on LLJ results

Under the auspices of CEN, LLJ has initiated a process to achieve Workshop Agreements based on the techniques developed by Prof. Joanne Tipper and team at the University of Leeds who have been working on in vitro testing of the silicon nitride coating. Preparation of the workshops has been coordinated by Dr Peter Hatto, Ionbond and Jacqui Burman of BSI.

CEN/WS 87 – “Novel methods for isolating wear particles from joint replacements and related devices and for evaluating their biological impact in vitro” will hold a web based kick-off meeting 15 June 2017. Details on how to participate can be found on the CEN website .

The Workshop aims at producing two CEN Workshop Agreements. It will deliver

  1. new wear particle isolation procedures that will allow the collection and subsequent biological testing of wear debris from joint simulator and reciprocating wear testing under joint relevant conditions and
  2. a toolkit of tests providing a significantly more relevant, and complete measure of biological impact of wear particles by considering inflammatory cytokine release, cytotoxicity, genotoxicity, oxidative stress and membrane toxicity.

LLJ Partner Uppsala University uses LLJ to present the excitement of science to the wider community

SCIFEST 2017 is a festival of science organised  in Uppsala which reaches out especially to schoolchildren and their teachers as well as the general public. Through workshops, shows, competitions opportunities to meet researchers and lectures, people of all ages have a chance to be inspired by the excitement of science and its application. The Uppsala team led by Cecelia Persson were present and used the opportunity to present some of their materials work for LLJ.

www.teknik.uu.se/…

LLJ Lead researcher honoured in UK New Year Honours List

Anne Neville’s, Professor of Tribology and Surface Engineering, School of Mechanical Engineering, University of Leeds, distinguished career and contribution to engineering has been honoured. She has been made an Officer of the (Most Excellent) Order of the British Empire (OBE) in the UK New Year’s Honours list for services to engineering. Among many achievements cited, her research group was the first to be able to monitor corrosion in a full hip joint simulator, which enabled the team to understand corrosion processes and link this to lubrication of the joint in a way previously not possible. LLJ is building on this knowledge.read more

LLJ moving into its final phase reaches consensus on exploitation scenarios

LLJ held a technical discussion meeting at ETH Zürich 1-2 November focussing on reviewing the coating development and test results. Since commencement of the project the market for hard-on-hard implants has collapsed to be replaced largely by hard on polyethylene systems. This has posed some questions about which product scenarios should now be the focus of the project work to offer the best exploitation opportunities. In concluding the meeting, the scientific coordinator Prof. Richard Hall noted the tremendous progress that had been made and the consensus established around how to move forward to the conclusion of the project.